Cradle Genomics: Illumina alums launch Cradle Genomics with $17.1M for first-trimester fetal DNA testing
Prenatal blood test developer Cradle Genomics has secured $17.1 million to help build out its laboratory operations, as well as kick off clinical testing of its methods for fetal genetic testing and pregnancy health screening within the first trimester.
Read full article »
Cradle Genomics is a prenatal testing company that provides genetic analysis and pregnancy health screening solutions for women.
Read more